BioLife Solutions stockholders re-elect directors, approve executive compensation and 2023 Incentive Plan

BIOLIFE SOLUTIONS INC

Re-elected all seven director nominees: Michael Rice, Joydeep Goswami, Joseph Schick, Amy DuRoss, Rachel Ellingson, Roderick de Greef, and Timothy Moore.
Approved non-binding advisory vote on named executive officer compensation: 28,011,724 for, 5,972,831 against.
Ratified appointment of Grant Thornton LLP as independent auditor for FY2023: 38,080,800 votes for.
Approved 2023 Omnibus Performance Incentive Plan: 32,018,463 votes for, 1,961,503 against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOLIFE SOLUTIONS INC shareholders approved Ratification of the appointment by the Board of the Company of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-07-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-07-21

Exact text from the filing

Proposal No. 3 - Ratification of the appointment by the Board of the Company of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOLIFE SOLUTIONS INC shareholders approved Election of directors: Michael Rice, Joydeep Goswami, Joseph Schick, Amy DuRoss, Rachel Ellingson, Roderick de Greef, and Timothy Moore at the 2023-07-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-07-21

Exact text from the filing

Proposal No. 1 - Election of directors . Michael Rice, Joydeep Goswami, Joseph Schick, Amy DuRoss, Rachel Ellingson, Roderick de Greef, and Timothy Moore were elected to serve until the 2024 annual meeting of stockholders or until his or her successor is duly elected and qualified or until his or her earlier resignation or removal or otherwise is disqualified from serving as a director of the Company.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOLIFE SOLUTIONS INC shareholders approved Approval of the 2023 Omnibus Performance Incentive Plan at the 2023-07-21 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-07-21

Exact text from the filing

Proposal No. 4 - Approval of the 2023 Omnibus Performance Incentive Plan . The 2023 Omnibus Performance Incentive Plan was approved.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIOLIFE SOLUTIONS INC shareholders approved Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers at the 2023-07-21 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-07-21

Exact text from the filing

Proposal No. 2 - Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers. The compensation for the Company’s named executive officers, by non-binding advisory vote, was approved.

View on SEC.gov

Browse all shareholder votes →

BIOLIFE SOLUTIONS INC filing history →

Source: SEC EDGAR

accession 0001628280-23-025959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.